pretickt

McKesson Corporation (MCK)

Healthcare · end-of-day data as of Oct 16, 2026

McKesson Corporation
MCK · $117B
$1,004.84+19.6%last 60 sessions · close Oct 16, 2026
$723.60$1,004.8452 weeks
Buy · 17 analystsPT $990.13 -1.5%
  • P/E vs own+19.0%
  • P/E vs sector-4.5%
  • Target upside-1.5%
  • Off 52w high0.0%
  • Insiders-$368K
  • FCF yield+5.3%
  • Earnings in19d
  • Trendsideways
  • Sector▲ +16.0%
  • RSI76
  • MA20×50—
  • Volume0.9x
  • Support-7.1%
  • Resistance—

The average 12-month analyst price target for MCK is $990.13, 1.5% below the last close of $1,004.84 on Oct 16, 2026; targets range from $829.00 to $1,207.45. Rating consensus: Buy.

Snapshot

  • P/E26.9x
  • P/E vs sector-4.5%
  • P/E vs own+19.0%
  • Target upside-1.5%
  • ConsensusBuy
  • Market cap$117B
  • FCF yield+5.3%
  • Insiders-$368K
  • Earnings in19d
  • News0.00

Why it moved

McKesson Corporation (MCK) rose 0.6% on Oct 16, 2026.

The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move is specific to MCK.

Market (SPY)-1.1%
Healthcare sector+0.4%
MCK specific+1.4%

0 stories on the day (30-day average 1.3).

Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.

Price and events

⇔⇕$742$823$905$987Oct 25Jan 26Apr 26Jul 26Oct 26EDEDEDEDE

Last close $1,004.84 · +30.1% over 1y · E earnings · D dividend · S split · A analyst rating change

Technicals

  • Trendsideways
  • Sector▲ +16.0%
  • MAs20▲ 50▲ 100▲ 200▲
  • Above MAs4 of 4 above
  • MA20×50—
  • RSI76
  • Support-7.1%
  • Resistance—
  • Off 52w high0.0%
  • Off ATH0.0%
  • 52w range$1,004.84
  • Bollingerabove upper
  • MACD10.87
  • ATR+2.2%
  • Volume0.9x

Analyst price targets

Low$829.00
Average$990.13
Median$982.35
High$1,207.45
Upside-1.5%

10 firms with a target in the last 12 months · last close $1,004.84 · as of Oct 16, 2026

⇔⇕$699$832$966$1,099$1,232Oct 25Mar 26Aug 26Jan 27Jun 27-4%+0%-16%+3%-5%-2%+20%
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets

Strong buy 3 · Buy 10 · Hold 4 · Sell 0 · Strong sell 0

Revenue and free cash flow

Q1 FY2027: Revenue +7.7% year over year, free cash flow -0.3% of revenue, operating margin 1.3%.

RevenueFree cash flow
Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Q1 FY2027Jun 30, 2026$105B5.15-$332M3.5%1.3%0.6%
Q4 FY2026Mar 31, 2026$96.3B13.71$3.24B4.2%2.3%1.7%
Q3 FY2026Dec 31, 2025$106B9.59$1.06B3.5%1.5%1.1%
Q2 FY2026Sep 30, 2025$103B8.92$2.22B3.4%1.4%1.1%
Q1 FY2026Jun 30, 2025$97.83B6.25-$1.11B3.4%1.1%0.8%
Q4 FY2025Mar 31, 2025$90.82B10.01$7.47B3.2%1.1%1.4%
Q3 FY2025Dec 31, 2024$95.29B6.94-$2.58B3.4%1.4%0.9%
Q2 FY2025Sep 30, 2024$93.65B1.86$1.88B3.4%0.8%0.3%

Peers

20D
1BMYBristol-Myers Squibb Company$59.75-1.4%-11.3%+9.4%13.2$122B
2MDTMedtronic Plc$94.75-0.7%-7.1%+4.0%23.3$121B
3CVSCVS Health Corp.$92.36-0.2%-16.0%+20.9%24.4$118B
4MCKMcKesson Corporation$1,004.84+0.6%0.0%-1.5%26.9$117B
5SYKStryker Corporation$294.66+0.5%-23.3%+23.9%30.5$113B
6CORCencora, Inc.$340.92-0.1%-8.5%+6.8%25.3$65.06B
7CAHCardinal Health, Inc.$254.06+0.1%0.0%+4.5%35.1$58.83B
8HSICHenry Schein, Inc.$86.38-0.7%-4.9%+6.0%25.2$9.63B

Data as of Oct 16, 2026 close.

Latest news

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.